← All organizations

Kyorin Pharma

For profit

Also known as: Kyorin Pharmaceutical Co.,Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 15, 2022

Timeline

1920s

Jan 1, 1923
Kyorin Pharma— Founded

2000s

Dec 1, 2004
ActivX Biosciences, Inc.— Acquired

Drugs by trial phase (7 distinct, 6 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Efzofitimod

Phase 2 (0 own, 2 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

ActivX Biosciences, Inc.

Recent trials (8)

NCT05415137CollaboratorPhase 3Sep 15, 2022
NCT04908800Lead sponsorPhase 1May 27, 2021
NCT04908800Study chairPhase 1May 27, 2021
NCT01578304CollaboratorPhase 4Dec 1, 2010
NCT00995345CollaboratorPhase 2Oct 1, 2009
NCT00525330CollaboratorPhase 2Sep 1, 2007
NCT00512785Study directorPhase 3Aug 1, 2007
NCT00512785CollaboratorPhase 3Aug 1, 2007

Details

Founded: Tokyo, JP Jan 1, 1923
Last known activity: Sep 15, 2022